Eustachian tube device and method

ABSTRACT

Devices are provided for insertion into a Eustachian tube of an animal, e.g., a human being. The devices may include an insertable member, an immobilizing means and a fluid-communication providing means. The member has opposing surfaces and is formed at least in part from a biocompatible material that is degradable. The fluid-communication providing means is effective to provide sufficient fluid communication between the opposing surfaces of the insertable member to effect pressure equilibration therebetween. The immobilizing means is effective to immobilize the device within the Eustachian tube for a predetermined period. Also provided are kits that include the device and methods for inserting the device into a Eustachian tube.

CROSS REFERENCE TO RELATED APPLICATIONS

This application is a divisional of U.S. patent application Ser. No.11/678,919, entitled “Eustachian Tube Device and Method,” filed on Feb.26, 2007, by inventor Aditi H. Mandpe, now allowed, which claimspriority to U.S. Provisional Patent Application Ser. No. 60/767,020,entitled “Eustachian Tube Dilator and Stent,” filed on Feb. 27, 2006, byinventor Aditi H. Mandpe, the disclosures of which are incorporated byreference in their entirety.

BACKGROUND

1. Technical Field

The invention generally relates to devices for insertion into aEustachian tube. In particular, the invention relates to devices thatinclude an insertable member, a means for immobilizing the device, ameans for providing sufficient fluid communication between opposingsurfaces of the insertable member to effect pressure equilibrationtherebetween, and to methods for using such devices.

2. Background Art

The Eustachian tube is a hollow lined tube that connects a middle ear tothe nasopharynx. The middle ear portion of the tube can only be accessedby incising the eardrum or ear canal skin. The nasal portion of the tubeis surrounded by cartilage that regulates opening and closing actions(torus tubarius). In its resting state, the Eustachian tube is in theclosed position. Eustachian tube opening action is mediated bycontraction of surrounding muscles that impinge upon the tube and torustubarius. An opened tube ventilates and drains the middle ear andmaintains proper pressure relationships among the eardrum, middle ear,and nasopharynx.

Eustachian tube dysfunction has been implicated in the development ofvarious otologic diseases. The etiology of acute otitis media ishypothesized to be due to bacteria traveling into the middle ear fromthe nasal cavity in a setting of inflammation, which prevents the middleear from draining properly. Chronic otitis media occurs when theEustachian tube fails to ventilate the middle ear over an extendedperiod. In these cases, fluid and thickened mucosa accumulate in themiddle ear, causing hearing loss. As difficulty ventilating the middleear continues, skin may become entrapped (cholesteatoma), and causechronic infection and destruction of the ossicles, inner ear and mastoidair cell system.

Eustachian tube dysfunction is especially problematic for patients whoare unable to clear their ears when flying and diving. In the setting ofrapidly changing barometric conditions, as in flying and diving,inability to ventilate the middle ear sufficiently can lead tobarotrauma with accumulation of fluid or blood in the middle ear. Onoccasion, Eustachian tube dysfunction patients can experience eardrumrupture, deep hearing loss and dizziness.

Treatment of Eustachian tube dysfunction has mainly been directed atventilation of the middle ear via the eardrum or tympanic membrane.Typically, a myringotomy or incision through the substance of theeardrum is created, and a ventilation tube is placed within theincision. These ventilation tubes or grommets have been commerciallyavailable for over 50 years.

Such treatments are associated with numerous drawbacks. For example,ventilation tubes are typically spontaneous and uncontrollably extrudedfrom the eardrum about 4-9 months after placement. The invasiveness ofsurgical procedures to the eardrum or tympanic membrane also representsa potential source of complications

Some long-term solutions have been proposed. U.S. Pat. No. 3,807,409 toPaparella et al. and U.S. Pat. No. 4,695,275 to Bruce et al. describeeardrum-based methods and modified ventilation tube flanges to promotelengthier tube retention periods. U.S. Pat. No. 3,982,545 to Silversteinand U.S. Pat. No. 5,047,053 to Jahn describe methods of ventilation tubeinsertion by modifying the ear canal. The materials used for ventilationtube construction for U.S. Pat. No. 3,982,545 is silicone and U.S. Pat.No. 5,047,053 is biointegratable hydroxyapatite. These prostheses may beextruded at variable times and require complex office or operating roomprocedures to clear debris that surrounds the ventilation tubes.

Direct stenting of the Eustachian tube through the middle ear orificehave been proposed. Devices for carrying out such Eustachian tubestenting have been described, for example, in U.S. Pat. No. 4,015,607 toWright, III, U.S. Pat. No. 6,589,286 to Litner and PCT/JP2005/020014. Asa short-term solution, Litner describes an elongated, drug-eluting stentdesigned to be secured at the tympanic orifice as a short-term solutionto maintain the patency of the Eustachian tube. In contrast, the Wrightapparatus is designed as a long-term solution. Long-term Eustachian tubestenting via the middle ear have resulted in unplanned tube extrusion,mucosal inflammation of the Eustachian tube and blockage. In any case,these apparatuses are placed through either a myringotomy or incisioninto the ear canal.

Myringotomy can lead to persistent abnormalities with the eardrum. Inthe pediatric age group where myringotomy with ventilation tubeinsertion is a common procedure, the most concerning complication ispermanent eardrum perforation. When eardrums heal after myringotomy,many are clearly abnormal, such as, formation of retraction pockets,thin atrophic membranes, and tympanosclerosis. The impact of theseundesirable changes is hearing loss that ranges from 3-5 decibels (dB).Incision into the ear canal is a more technically complex surgicalprocess. Bleeding in the ear canal and scarring of the eardrum arecommon outcomes.

While previous methods of relieving Eustachian tube dysfunction andassociated problems have been focused on the middle ear component, thereis recent indication that treatment at the nasopharynx component ispromising. A successful method and apparatus for the treatment ofEustachian tube dysfunction at the torus tubarius location would be freeof undesirable outcomes associated with eardrum and ear canal basedsurgical procedures. Poe et al. (2003), “Laser Eustachian Tuboplasty: APreliminary Report,” LARYNGOSCOPE, 113(4):583-91, describes a surgicalprocedure which involves partial excision of the cartilaginous portionof the torus tubarius to increase the opening size. This surgicalprocedure has been effective in preventing the need to replaceventilation tubes in 70% of patients with chronic otitis media.

A non-surgical device that acts to enlarge the torus tubarius apertureon a temporary basis appears to be effective in chronic otititis media.The EarPopper™ delivers a pressure controlled constant volume velocityof air through the nose to the Eustachian tube orifice in thenasopharynx. As disclosed in Arick et al. (2005), “Nonsurgical hometreatment of middle ear effusion and associate hearing loss in children.Part I: Clinical trial,” EAR, NOSE, THROAT JOURNAL, 85(10):1-13, such adevice has been used to restore hearing to normal in 85% of patientswithout antibiotics or ventilation tubes over 7 weeks.

Nevertheless, opportunities exist to overcome disadvantages associatedwith known technologies associated with the treatment of disordersassociated with an obstructed Eustachian tube.

SUMMARY

In a first embodiment, a device is provided for insertion into aEustachian tube of an animal, e.g., a human. The device includes, insome instances consists essentially of, an insertable member, animmobilizing means and a fluid-communication providing means. The memberhas opposing surfaces and is formed at least in part from abiocompatible material that is degradable in the Eustachian tube at apredetermined degradation rate. The fluid-communication providing meansis effective to provide sufficient fluid communication between theopposing surfaces of the insertable member to effect pressureequilibration therebetween. The immobilizing means is effective toimmobilize the device within the Eustachian tube, typically at alocation closer to a nasopharynx than an eardrum, for a predeterminedperiod of time that corresponds to the predetermined degradation rate.

Typically, the predetermined period is selected to allow Eustachian tubefunction to be restored without having trauma to the Eustachian tubemucosa that potentially may lead to scarring. For example, theimmobilization means may have a construction such that degradation ofthe biocompatible material of the device after the predetermined periodwithin the Eustachian tube leads to a substantially complete extractionof the member from the Eustachian tube. Such extraction may be carriedout with or without surgical intervention.

Member geometry may vary. Typically, at least one opposing exteriorsurface is associated with a member length and member width and theperipheral surface is associated a member thickness such that the memberlength is greater than the member thickness. In some instances, themember may have a geometry effective to allow the peripheral surface ofthe member to engage a surface of the Eustachian tube, therebysubstantially immobilizing the device within the Eustachian tube uponinsertion therein. In such a case, at least one exterior surface mayhave a substantially triangular shape that corresponds to a crosssectional area of the Eustachian tube. Optionally, the member geometrymay exhibit mirror symmetry. In addition, thefluid-communication-providing means may include or consist essentiallyof a hole extending through the member between the opposing exteriorsurfaces, the hole being substantially dimensionally stable for at leastthe predetermined period after the device is inserted into theEustachian tube.

The device may be provided in a kit that also includes an insertionapparatus, e.g., a spring-loaded hand-held endoscopic apparatus, in anoptional container with optional instructions for using the apparatus.The insertion apparatus may be releasably engageable with the device.For example, the device may be constructed to engage the device via thefluid-communication-providing means.

In another embodiment, a method is for inserting a device into aEustachian tube of an animal. The device may be inserted, using anoptionally insertion apparatus, through a nostril or mouth of the animalinto the Eustachian tube. The device may then be released mannereffective to allow the device to immobilize itself within the Eustachiantube.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 depicts in front view an exemplary device of the invention in theform of a Eustachian tube dilator and stent.

FIG. 2 depicts in side view the device shown in FIG. 1.

FIG. 3 shows in perspective view of the device shown in FIG. 1.

FIGS. 4 a and 4 b, collectively referred to as FIG. 4, show crosssectional views near the bottom and top, respectively, of the deviceshown in FIG. 1.

FIG. 5 depicts the placement of the device of FIG. 1 in position in theEustachian tube at the torus tubarius.

DETAILED DESCRIPTION OF THE INVENTION DEFINITIONS AND OVERVIEW

Before describing the present invention in detail, it is to beunderstood that the invention is not limited to devices and methods thatprovide pressure equilibration in any specific manner, for particularfluids and/or for treatment any specific disorders, as such may vary. Itis also to be understood that the terminology used herein is for thepurpose of describing particular embodiments only, and is not intendedto be limiting.

In addition, as used in this specification and the appended claims, thesingular article forms “a,” “an,” and “the” include both singular andplural referents unless the context clearly dictates otherwise. Thus,for example, reference to “an apparatus” includes a single apparatus aswell as an assembly of apparatuses, reference to “a hole” includes aplurality of holes as well as a single hole, and reference to “amaterial” includes a single material as well as a combination ofmaterials, and the like.

In this specification and in the claims that follow, reference will bemade to a number of terms that shall be defined to have the followingmeanings, unless the context in which they are employed clearlyindicates otherwise:

The term “biocompatible” refers to the ability of the compositions ofthe present invention to be applied to tissues without elicitingsignificant inflammation, fibrosis, or tissue responses that are toxic,injurious or otherwise adverse.

The term “fluid” as used herein in its ordinary sense and refers to anat least partially gaseous and/or liquid substance that easily changesits shape. A fluid may contain a solid that is minimally, partially, orfully solvated, dispersed, or suspended. Examples of fluids include,without limitation, gases (such as oxygen, nitrogen, carbon dioxide,water vapor, and mixtures such as air), aqueous liquids (including waterper se, salt water, and physiologic saline solutions), nonaqueousliquids (such as organic solvents, oils and the like), fluid emulsions,suspensions, and/or solutions such as mucus, blood, plasma, lymph,interstitial fluids, etc.

Accordingly, the term “fluid-communication,” unless the context of itsusage clearly indicates to the contrary, generally encompasses termssuch as “air-communication,” and “mucus-communication.”

“Optional” or “optionally” means that the subsequently describedcircumstance may or may not occur, so that the description includesinstances where the circumstance occurs and instances where it does not.

The term “polymer” and “polymeric” refer to a molecule consisting ofindividual chemical moieties, which may be the same or different, butare preferably the same, that are joined together. As used herein, theterm “polymer” refers to individual chemical moieties that are joinedend-to-end to form a linear molecule, as well as individual chemicalmoieties joined together in the form of a branched structure.

The term “resorbable” is used herein in its ordinary sense and describesa degradable material that can be both dissolved in and biologicallyassimilated by a patient.

The terms “substantial” and “substantially” are referred to herein intheir ordinary sense and are used to describe matters that are, e.g.,considerable in importance, value, degree, amount, and/or extent. Forexample, a device that is “substantially immobilized” in the Eustachiantube is neither required nor precluded from absolute immobilization aslong as movability of the device in the Eustachian tube is reduced to agenerally trivial degree that does not compromise the intendedfunctionality of the device within the Eustachian tube. Other uses ofthe term “substantially” involve an analogous definition.

In general, the invention pertains to devices, apparatus and method forinserting a device into a Eustachian tube of an animal. Typically, thedevice is used to dilate, provide mechanical support, and/or stent theEustachian tube at location closer to a nasopharynx than an eardrum,e.g., the torus tubarius orifice, which in turn, maintains patency ofthe Eustachian tube. The method of placement of the apparatus is via thenasal and/or oral passages and nasopharyngeal opening of the Eustachiantube and does not require incision of the eardrum, ear canal or entryinto the middle ear.

In some instances, the device includes an insertable member, animmobilizing means and a fluid-communication providing means. The memberhas opposing surfaces and is formed at least in part from abiocompatible material that is degradable in the Eustachian tube at apredetermined degradation rate. The fluid-communication providing meansis effective to provide sufficient fluid communication between theopposing surfaces of the insertable member to effect pressureequilibration therebetween.

The construction of the inventive device may vary depending on thefunctionality desired. As an initial matter, the device should beconstructed according to the physiology of the animal into whoseEustachian tube is intended to receive. As the invention may be used forany animal having a Eustachian tube, the invention may be constructedfor humans (e.g., patients who are infants, children, teenagers, adults,and seniors), domesticated animals such as dogs, cats, horses, cattle,and pigs, and nondomesticated animals.

The predetermined rate may be selected according to a plurality ofselection criteria, singly and in combination. For example, when thedevice is constructed to treat a disorder associated with the Eustachiantube, the rate may be chosen to ensure restoration of proper Eustachiantube function within a predetermined period without having trauma to theEustachian tube mucosa that potentially may lead to scarring. In someinstances, the predetermined rate may correspond to a predeterminedperiod of about 2-8 weeks to allow fluid to sufficiently drain from anacute infection and allow the Eustachian tube function to be restored.In some instances, the predetermined period may be closer to about 2-3weeks. In addition, once the tube is properly functioning, keeping theopening stented for an excessive time period may lead to an unexpectedproblem with an echo in the ear while speaking. Accordingly, thepredetermined period typically does not exceed about one year. Onoccasion, the device may be surgically removed.

When placed in the Eustachian tube at the torus tubarius, e.g., througha minimally invasive procedure that results in device placement throughthe nasal passages or through the oropharynx under the palate, thedevice confers a number of advantages previously unknown in the art. Forexample, the benefits of a nasopharyngeal-based therapy may be achievedwithout the disadvantages of the undesirable outcomes associated withtreatment methods that involve an incision in the ear canal or eardrum,or entry into the middle ear space. In addition, such placement of thedevice in the Eustachian tube may provide immediate relief from fluid inthe ear and pressure related maladies.

As the device renders the Eustachian tube patent, the device may aeratethe middle ear, become a portal to drain fluid and infection from themiddle ear, treat retracted eardrums and ear congestion, and preventpressure related damage to the ear associated with activities such as,airplane travel, diving, and high altitude activities. The device mayalso enable diagnostic microendoscopy of Eustachian tube and the middleear, and serve as a conduit for the diagnosis and assessment of middleand inner ear functions, integrity of the ossicles, chronic earinfection and cholesteatoma. Further, the device may serve as a stentand protective dressing for any hard and soft palate, nasopharyngeal, orEustachian tube surgery.

An Exemplary Device

The invention provides, in an exemplary embodiment, a device constructedfrom biocompatible and bioresorbable implantable materials withbiomechanical properties that provide opening forces necessary to keepthe Eustachian tube orifice patent. The device includes an insertablemember that has a triangular shaped arch with a central opening thatdilates and stents the Eustachian tube, and ventilates the middle ear.The insertable member has a contoured lip that allows the device to besnapped into position at the nasopharyngeal orifice of the Eustachiantube. The device has structural memory to maintain its shape and acentral hole to ventilate the middle ear.

FIGS. 1-4 show such an embodiment of the invention in the form of adevice 1 that may serve as Eustachian tube dilator and stent for a humanpatient. As is the case with all figures referenced herein, in whichlike parts are referenced by like numerals, FIGS. 1-4 are notnecessarily to scale, and certain dimensions may be exaggerated forclarity of presentation. As shown in FIG. 1, the device 1 includes aninsertable member 10 having a first exterior major surface 12 having ashape generally corresponding to an acute isosceles. Such a shape alsogenerally corresponds to the cross sectional area of the torus tubariusopening for a Eustachian tube of an ordinary human patient. The devicehas a width indicated by A, which corresponds to the widest dimension ofthe member's bottom end 3. Width A may range from about 3 mm to about 8mm, but is typically about 5 mm. As shown, the bottom portion of thedevice exhibits a generally flanged geometry. The device has a lengthindicated by B, which corresponds to the distance between the top end 2and the bottom end 3 of the member 10. Length B may extend about 6 mm toabout 12 mm, but is typically about 9 mm.

FIG. 2 depicts the device of FIG. 1 in side view. As shown in FIG. 2,the device also has a second major exterior surface 14. Surfaces 12 and14 are both planar, have a substantially identical shape, and areparallel to each other. The thickness of the device is generally uniformand indicated by C, which represents the distance between surfaces 12and 14. Though thickness C may range from about 2 mm to about 4 mm, C istypically about 2 mm.

As shown in FIGS. 1 and 2, a central ventilating hole 20 having agenerally circular shape serves as a means for providing fluidcommunication between major surfaces 12 and 14. Hole 20 has a diameter Dthat is typically about 3 mm, but may range from about 2 mm to about 4mm. The dotted lines of FIG. 2 represent side walls of the hole 20carried from FIG. 1 and serves to indicate the upper and lower extent ofthe central ventilation hole 20. As shown, the hole 20 extends in asubstantially perpendicular orientation relative to surfaces 12 and 14.Four optional protrusions 40 extend from first surface 12 and may serveas insertion flanges.

The overall geometry of the device 1 in perspective view is representedin FIG. 3. As shown, the device member 10 has a triangular arched shapedstructure with the central ventilating hole 20. The first surface 12 andthe second surface (not shown) are connected by a peripheral surface 50,which generally encircle the device 1.

FIG. 4 represents cross-sectional views of the device along a-a and b-blines in FIG. 1. As shown in FIG. 4, the peripheral surface 50 takes theform of a concave groove bounded by contoured lips 30. In someinstances, contoured lips 30 start from one lateral aspect of device 1near its bottom 3, cross the top 2 and terminate at the correspondingopposing lateral aspect of the device 1. The groove and lip constructionmay serve as a means for immobilizing the device.

FIG. 5 shows the device 1 in context with for proper positioning in thetorus tubarius 120 of a human patient to achieve Eustachian tubepatency. FIG. 5 contains a cross-sectional representation of the earalong the external auditory canal and length of the Eustachian tube 90.The external ear or pinna 60 is the most lateral structure. The eardrum70 and middle ear space 80 are not violated in the insertion process.The Eustachian tube orifice or torus tubarius 120 resides within thenasopharynx 100. When the device 1 is properly positioned, the lips 30and groove 50 allows the device 1 to be snapped into the anterior andposterior lips of the torus tubarius 120.

Device Geometry and Construction

As discussed above, device geometry and construction may vary accordingto its functionality. In general, the device includes or consistsessentially of an insertable member, an immobilizing means and afluid-communication providing means. The member has opposing surfacesand is formed at least in part from a biocompatible material. Thefluid-communication providing means is effective to provide sufficientfluid communication between the opposing surfaces of the insertablemember to effect pressure equilibration therebetween.

The opposing surfaces may be connected by a peripheral surface.Typically, at least one of the opposing surfaces represents a majorsurface of the member. In such a case, the major surface is associatedwith a member length and member width and the peripheral surface isassociated a member thickness. In addition, at least one exterior majorsurface may have a shape that substantially corresponds to a crosssectional area of the Eustachian tube. Though surfaces of the inventionmay be generally smooth, it may be possible to produce devices such thatany surface may have any desired contour, e.g., jagged, undulated, etc.

A number of optional features may be incorporated into the constructionof the inventive device to address certain manufacturing and/orfunctionality concerns. For example, to facilitate ease inmanufacturing, the opposing surfaces may be rendered substantiallyplanar and parallel to each other. As a result, the insertable membermay have a uniform thickness. In the alternative, the device may assumea gentle curvilinear contour in the front to back and top to bottomdimensions and have a non-uniform thickness profile.

The member length is typically greater than the member thickness.Typically, the device length exceeds the thickness by at least 50%. Insome instance, the device width is greater than the thickness as well.In any case, when a device is constructed for insertion into theEustachian tube for either ear, left or right, the device may have amember geometry that exhibits mirror symmetry.

Typically, the member and the immobilization means have an integratedconstruction. For example, the member may have a geometry effective toallow the peripheral surface of the member to engage a surface of theEustachian tube, thereby substantially immobilizing the device withinthe Eustachian tube upon insertion therein. In such a case, the devicemay have mechanical properties that provide forces necessary to renderthe device immobile, e.g., the member may be at least partiallyelastically deformable before immobilization. Optionally, the insertabledevice itself may be formed from a material compounded with one or moreadhesives.

Optionally, nonintegrated immobilization means may be used. For example,adhesives may be used containing compositions that allow the insertablemember to become anchored in place by mechanical and/or chemical means.In some instances, an adhesive may be applied as an interfacialcomposition between the insertable member and the Eustachian tube.

In any case, at least one exterior surface may have a substantiallytriangular shape that corresponds to a cross sectional area of theEustachian tube. For example, when the Eustachian tube includes a torustubarius defined at least in part by anterior and posterior pillarsmeeting at a top portion of the torus tubarius, the member may exhibit ageometry such that the peripheral surface is effective to engage atleast a portion of the torus tubarius so as to immobilize the device inthe Eustachian tube. In particular, the member geometry may be effectiveto allow a vertex portion of the peripheral surface to engage the topportion of the torus tubarius and/or allow side portions of theperipheral surface to engage anterior and posterior pillars of the torustubaris.

While in some rare instances the inventive device may be considered apermanent implant, the immobilization means is typically be provided ina manner that allows for the device to be engaged with the Eustachiantube temporarily for a predetermined period of time and to be disengagedfrom the Eustachian tube in a controlled manner. Typically, theimmobilization means has a construction such that degradation of thebiocompatible material of the device after the predetermined periodwithin the Eustachian tube leads to a substantially complete extractionof the member from the Eustachian tube. Such extraction may be carriedout with or without surgical intervention. Typically, the predeterminedperiod corresponds to the predetermined degradation rate of the devicematerial.

As is the case with the immobilization means, the fluid-communicationproviding means may vary in construction as well. In general, thefluid-communication-providing means may be effective to equilibrate anyfluid-generated pressure between the opposing surfaces, regardlesswhether the pressure is generated from gases and/or liquids. However, insome instances, the fluid-communication providing means may be selectivefor fluid type. For example, such means may be effective to equilibrateat least partially gas-generated or at least partially liquid generatedpressure between the opposing surfaces.

When provided as an integrated component of the insertable member, thefluid-communication providing means extend through any portion of theopposing surfaces so as to allow for pressure equilibrationtherebetween. In some instances, such means may be centrally locatedthrough the member. In the alternative, the means may be eccentric tothe top, bottom or side.

In a number of embodiments, the fluid-communication providing means mayinclude or consist essentially of a hole extending through the memberbetween the opposing exterior surfaces. The hole may have anycross-sectional shape, including, for example, circle, oval, square,triangular, hexagonal, etc. For ease in construction, the hole may havea constant cross-sectional area and shape along its length. Similarly,the hole may extend in a substantially perpendicular orientationrelative to the opposing surfaces. In any case, the member should have aconstruction such that a hole, when present as a fluid-communicationproviding means, is substantially dimensionally stable for at least thepredetermined period after insertion into the Eustachian tube. Were thehole to be reduced in size in the Eustachian tube environment, the holemay lose its pressure equilibration functionality.

Device Materials

The inventive device may be formed in part or in whole from a number ofmaterials. Device materials are typically selected so as to ensureoptimal device performance given the particular construction and/orgeometry of the device. Optionally, the device materials may be tailoredto the environmental conditions to which the device may be exposed wheninserted into the Eustachian tube. It is expected that the environmentalconditions of the Eustachian tube may vary according to a number offactors, e.g., the particular temperature of the animal whose Eustachianis to receive the device, whether the Eustachian tube is healthy ordiseased, whether pus or other bodily fluids are present, etc.

In some instances, the insertable member may be substantially uniform incomposition. However, the insertable member may be comprised of aplurality of regions that form an integrated whole. For example, themember, in some embodiments, may be comprised of an interior region anda peripheral region, wherein the regions exhibit different compositions.In such a case, at least the peripheral region may be formed from abiocompatible and resorbable or degradable material. The bulk andmicrostructure of the materials used with the invention should becontrolled in order to produce an insertable member of controlledmechanical properties (e.g., tensile strength, elasticity) andresorption properties. In such a case, the dual layer functionality mayprovide greater control over device performance.

Typically, the insertable member is formed in large part or entirelyfrom a biocompatible and optionally resorbable material that isnon-toxic, noninflammatory and nonimmunogenic. The material is typicallysynthetic or man-made. However, a naturally occurring composition may beused as well. Biocompatibility typically requires a material purity of apharmaceutically acceptable grade.

Materials for use with the invention may be selected in a manner toprovide precise control over device resorption/enzymatic degradationrate. Often, materials are employed comprising one or more hydrophiliccompound, mixtures thereof, copolymers of the forgoing, and combinationsof the aforementioned. Polymeric materials may be employed because theresorption rate may be established by controlling the molecular weightand/or the degree of crosslinking associated with the polymericmaterial. Suitable hydrophilic polymers used herein include polyethyleneglycol, polyoxyethylene, polymethylene glycol, polytrimethylene glycols,polyvinylpyrrolidones, and derivatives thereof. In some limitedinstances, polylactic acids may be employed as well. The polymers can belinear or multiply branched and will not be substantially crosslinked.Other suitable polymers include polyoxyethylene-polyoxypropylene blockpolymers and copolymers. Polyoxyethylene-polyoxypropylene block polymershaving an ethylene diamine nucleus (and thus having four ends) are alsoavailable and may be used in the practice of the invention.

One suitable material for use in the present invention comprises apolyethylene glycol (PEG) containing compound, due to its knownbiocompatibility. Various forms of PEG are extensively used in themodification of biologically active molecules because PEG can beformulated to have a wide range of solubilities and because it is low intoxicity, antigenicity, immunogenicity, and does not typically interferewith the enzymatic activities and/or conformations of peptides. Further,PEG monomers are generally non-biodegradable and is easily excreted frommost living organisms, including humans. Other synthetic polymericmaterials suitable for use include, for example, polyvinyl alcohols,polyacrylic acids, polyglycolic acids, polydioxanones.

In some instances, naturally occurring compounds may be employed to formthe insertable member. Suitable naturally occurring compounds include,but are not limited to: polysaccharides such as hyaluronic acid,cyclodextrin, hydroxymethylcellulose, cellulose ether, and starch;glycans such glycosaminoglycan and proteoglycan; and various proteins.

Proteins such as collagen and other collagenic (collagen-like) materialsmay be suited for use in the present invention. Collagen, in its nativeform, is typically a rigid, rod-shaped molecule approximately 300 nmlong and 1.5 nm in diameter. It is composed of three collagenpolypeptides, which together form a tight triple helix. The collagenpolypeptides are each characterized by a long midsection having therepeating sequence -Gly-X-Y-, where X and Y are often proline orhydroxyproline, bounded at each end by the “telopeptide” regions, whichconstitute less than about 5% of the molecule. The telopeptide regionsof the collagen chains are typically responsible for the crosslinkingbetween chains, and for the immunogenicity of the protein, and whenremoved, may allow collagenic compounds to serve as a biocompatibledevice member material.

Collagen occurs in several types, having distinct physical properties.Suitable collagenic materials include all types of pharmaceuticallyuseful collagen, e.g., types I, II, and III. Collagens may be fibrillaror non-fibrillar, e.g., methylated or succinylated. In some instances,collagen crosslinked and/or conjugated using heat, radiation, orchemical agents such as glutaraldehyde may be employed.

The invention may be used in conjunction with pharmaceuticaltechnologies known in the art. For example, the device member mayinclude a pharmacologically active constituent. Such constituents may bebound to the device member or may be eludable. Such pharmacologicallyactive constituents may promote post-operative healing and may include,for example, antibiotics, antifungal agent, anti-inflammatory, or thelike. In the alternative, the biocompatible material may be free fromany pharmacologically active constituents.

The device according to the present invention may be produced in anumber of ways. One simple method involves pouring a sterile solution ofa precursor member material into a sterile mold cavity to harden. Themold cavity may be composed of stainless steel, elastomeric orthermoplastic tubing, glass, or other substances. Optionally, areleasing agent is interposed between the mold and the solution. Whilethe device member according to the present invention may be cast with afluid-communication providing means extending the member, the member maybe cast solid and bored to produce a hollow communication passagetherethrough.

Extrusion may be employed as well to form the inventive device. Most ifnot all of the above-described materials may be formulated for extrusionthrough a suitable orifice. Depending on the particular formulation,crosslinking may occur during or after extrusion.

Generally, the microstructure of the materials used with the inventionshould be controlled in order to produce an insertable member ofcontrolled mechanical properties (e.g., tensile strength, elasticity)and resorption properties. For example, increasing the degree ofcrosslinking in the member compositions tends to increase the device'stensile strength, rigidity, and resistance to resorption.

Eustachian Tube Methods

In another embodiment, the invention also provides a method forinserting a device into a Eustachian tube of an animal. The methodinvolves inserting the device as described above through a nostril ormouth of the animal into the Eustachian tube. Optionally, the device isinserted solely through the nasopharyngeal opening of the Eustachiantube through the nose or the oropharynx in a manner that does notinvolve making any incision to an eardrum or ear canal skin. The devicemay then be released manner effective to allow the device to immobilizeitself within the Eustachian tube at its opening in the nasopharynx. Themethod may be performed with local anesthesia or sedation asappropriate.

Depending on the particulars of the nasal cavity configuration, thedevice may be inserted into the mouth or whichever nostril that allowsfor greater ease for device placement in either the right or leftEustachian tube. In particular, the device may be placed through thenasal passages or through the oropharynx under the palate.Advantageously, the method does not require an incision in the ear canalor eardrum, or entry into the middle ear space.

The method may involve the use of an insertion apparatus. For example,the method may involve loading onto an insertion apparatus and using theinsertion apparatus to insert the device through a nostril or mouth ofthe animal into the Eustachian tube. Once the device is in place, thedevice may be released from the apparatus in a manner effective to allowthe device to immobilize itself within the Eustachian tube.

Once the device has been properly positioned and immobilized, theEustachian tube remains patent. During the device-induced patency of theEustachian tube, the middle ear is aerated. The device effectivelybecomes a portal to drain fluid and infection from the middle ear.

The inventive method may be carried out, optionally through endoscopy,in conjunction with surgery or in the absence of any incision.Regardless whether the Eustachian tube into which the device is insertedis surgically unaltered or altered, the method may be effective todilate the Eustachian tube temporarily or permanently. Furthermore, themethod may be effective to prevent collapse of the Eustachian tubeand/or involve insertion of the device into an enlarged Eustachian tube.

The inventive method and device may be used to treat certain types ofhearing loss, tinnitus, ear discomfort and headache. The method cantreat dysfunction of the Eustachian tube due to scarring from surgery,radiation treatment, infection and inflammation affecting the Eustachiantube. The device also enables diagnostic microendoscopy of Eustachiantube and the middle ear, and serves as a conduit for the diagnosis andassessment of middle and inner ear functions, integrity of the ossicles,chronic ear infection and cholesteatoma. Further, the device serves as astent and protective dressing for any hard and soft palate,nasopharyngeal, or Eustachian tube surgery.

Still further, the invention may be effective to treat retractedeardrums and ear congestion. By dilating and stenting the Eustachiantube, barometric Eustachian tube dysfunction may be treated, andpressure related damage to the ear associated with activities such as,airplane travel, diving, and high altitude activities may be prevented.Allergic and/or infectious Eustachian tube dysfunction may also betreated. Both chronic and acute Eustachian tube dysfunction may betreated.

Insertion Apparatuses and Kits

As discussed above, an insertion apparatus may be used to place thedevice into and/or extract the device from the Eustachian tube. Theinsertion apparatus may have any of a number of designs andconstruction. The insertion apparatus, in some embodiments, isendoscopic and hand held in construction. The apparatus should provide auser sufficient degree of control over the insertion and/or extractionof the device in a minimally invasive manner so as to minimize trauma ordiscomfort to a patient. Thus, the apparatus may provide for preciselyand accurately controlled translational (e.g., X-Y-Z) and/or, rotational(θ−φ) movement capabilities. The apparatus may allow for one, two,three, four, five, six, or more degrees of freedom.

For example, the apparatus may have a device-interfacing terminus and amanipulation terminus. The device-interfacing terminus may have aconstruction specific to the inventive device or may be used tointerface with devices other than those described herein. For example,the interfacing terminus may have a solid or hollow geometry specific tothe inventive device. In some instances, the interfacing terminus mayalso provide for functionality associated with the practice of theinventive method. Exemplary functionality include suction, aspiration,delivery of air or medications to the middle ear.

The manipulation terminus may house a means for releasing any deviceengaged therewith. The releasing means may have a spring-loadedmechanism, or manual release mechanism that allows the inventive deviceto be releasably engageable with device-interfacing terminus of theapparatus. Optionally, the device may be controllably slid from theinsertion apparatus into the Eustachian tube.

In some instances, the inventive device may be constructed with a meansfor interfacing with the insertion apparatus. In some instances, suchmeans serve no other purpose than to interface with the insertionapparatus. For example, the interfacing means may include at least oneprotrusion extending from an exterior surface by which the insertiondevice may grab. As another example, one or more tabs or fenestrationsmay be located on either or both front and back surfaces of the devicearound the fluid-communication providing means.

In the alternative, the interfacing means may serve a plurality ofpurposes. For example, the fluid-communication providing means may havea construction effective to serve as means for engaging with theinsertion apparatus. When a hole is provided as the fluid-communicationproviding means, the insertion apparatus may be constructed to engagethe device via the fluid-communication-providing means through afriction fitting.

As another alternative, the interfacing means may be used to makeadjustments to the device to be inserted and/or extracted. For example,the interfacing means may be used to adjust the fluid-communicationproviding means. When the fluid-communication providing means is in theform of a central hole, the hole may be made smaller or larger throughthe insertion device. Such sizing may be carried out mechanically and/orremotely. For example, the central hole can be made larger through laserablation, or, in the alternative, be made smaller through controlledthermal activation or heat regulation.

The device may be packaged with the insertion apparatus to form a kit.Typically, the kit also includes container for containing the insertionapparatus and the device. Optionally, instruction for using theapparatus with the device may be included.

Variations of the present invention will be apparent to those ofordinary skill in the art in view of the disclosure contained herein.For example, while the geometry of the inventive device has beendescribed in detail for use with a living human patient, one of ordinaryskill in the art may take measurements from nonhuman animal cadavers todetermine the geometry required for such animals. Similarly, while thefluid-communication providing means has been generally described as asingle hole extending through the opposing surfaces of the insertablemember, such means may include a plurality of holes as well as no holes.Instead, a membrane that is selectively permeable to specific fluids maybe used as a fluid-communication providing means. Other variations ofthe invention may be discovered upon engage in routine experimentationduring the ordinary course of the practice of the invention.

It is to be understood that, while the invention has been described inconjunction with the preferred specific embodiments thereof, theforegoing description merely illustrates and does not limit the scope ofthe invention. Numerous alternatives and equivalents exist which do notdepart from the invention set forth above. In general, any particularembodiment of the invention may be modified to include or excludefeatures of other embodiments. Other aspects, advantages, andmodifications within the scope of the invention will be apparent tothose skilled in the art to which the invention pertains.

All patents, patent applications, and publications mentioned herein arehereby incorporated by reference in their entireties to an extent notinconsistent with the disclosure provided above.

1. A method for inserting a device into a Eustachian tube of an animal, comprising: (a) loading a device onto an insertion apparatus, the device comprising an insertable member that is sized for insertion within the Eustachian tube that defines a cross sectional area, the member having a preinsertion form that includes opposing exterior surfaces connected by a peripheral surface, wherein at least one opposing exterior surface defines a member length and member width, and the opposing exterior surfaces define a member thickness such that the member length is greater than the member thickness, means for immobilizing the device within the Eustachian tube upon insertion therein, and means for providing sufficient fluid communication between the opposing surfaces of the member to effect pressure equilibration therebetween; (b) using the insertion apparatus to insert the device through a nostril or mouth of the animal into the Eustachian tube; and (c) releasing the device from the apparatus in a manner effective to allow the device to immobilize itself within the Eustachian tube, thereby rendering patent the Eustachian tube for a predetermined time period.
 2. The method of claim 1, carried out in a manner without incising any ear drum or ear canal skin
 3. The method of claim 1, wherein the animal is human.
 4. The method of claim 2, wherein the member is formed at least in part from a biocompatible material that is degradable in the Eustachian tube at a predetermined degradation rate, and the immobilizing means is effective to immobilize the device within the Eustachian tube for the predetermined period of time that corresponds to the predetermined degradation rate.
 5. The method of claim 4, wherein the predetermined period is about two to about eight weeks.
 6. The method of claim 4, wherein the member is formed entirely from the biocompatible material.
 7. The method of claim 4, wherein the member has an interior region and a peripheral region, and the regions comprise different materials.
 8. The method of claim 7, wherein the peripheral region is formed from the biocompatible material.
 9. The method of claim 4, wherein the biocompatible material is free from any pharmacologically active constituent.
 10. The method of claim 4, wherein the biocompatible material includes a pharmacologically active constituent.
 11. The method of claim 10, wherein the pharmacologically active constituent is elutable from the biocompatible material.
 12. The method of claim 4, wherein the member and the immobilization means have an integrated construction such that the device is at least partially elastically deformable before immobilization.
 13. The method of claim 4, wherein the member includes the immobilization means and has a construction such that degradation of the biocompatible material of the device after the predetermined period within the Eustachian tube leads to a substantially complete extraction of the member from the Eustachian tube without surgical intervention.
 14. The method of claim 1, wherein the member has a geometry effective to allow the peripheral surface of the member to engage a surface of the Eustachian tube, thereby substantially immobilizing the device within the Eustachian tube upon insertion therein.
 15. The method of claim 14, wherein the Eustachian tube includes a torus tubarius defined at least in part by anterior and posterior pillars meeting at a top portion of the torus tubarius, and the member has a geometry such that the peripheral surface is effective to engage at least a portion of the torus tubarius so as to immobilize the device in the Eustachian tube.
 16. The method of claim 14, wherein the width is greater than the thickness.
 17. The method of claim 14, wherein the length exceeds the thickness by at least 50%.
 18. The method of claim 1, wherein the fluid-communication-providing means includes a hole extending through the member between the opposing exterior surfaces.
 19. The method of claim 18, wherein the member has a construction such that the hole is substantially dimensionally stable for at least the predetermined period after insertion into the Eustachian tube.
 20. The method of claim 1, further comprising (d) extracting the device from the Eustachian tube after the predetermined time period.
 21. A method for inserting a device into a Eustachian tube of a human, comprising: (a) loading a device onto an insertion apparatus, the device comprising an insertable member that is sized for insertion within the Eustachian tube that defines a cross sectional area, the member having a preinsertion form that includes opposing exterior surfaces connected by a peripheral surface, at least one of the exterior surfaces having a substantially triangular shape and size that corresponds to the cross sectional area of the Eustachian tube, and means for providing sufficient fluid communication between the opposing surfaces of the member to effect pressure equilibration therebetween; (b) using the insertion apparatus to insert the device through a nostril or mouth of the animal into the Eustachian tube; and (c) releasing the device from the apparatus in a manner effective to allow the device to immobilize itself within the Eustachian tube, thereby rendering patent the Eustachian tube for a predetermined time period.
 22. The method of claim 21, wherein the member has a geometry that exhibits mirror symmetry.
 23. A method for inserting a device into a Eustachian tube of a human, comprising: (a) loading a device onto an insertion apparatus, the device consisting essentially of an insertable member that is sized for insertion within the Eustachian tube that defines a cross sectional area, the member having a preinsertion form that includes opposing exterior surfaces connected by a peripheral surface, the exterior surfaces each having a substantially triangular shape and size that corresponds to the cross sectional area of the Eustachian tube, and means for providing sufficient fluid communication between the opposing surfaces of the member to effect pressure equilibration therebetween; (b) using the insertion apparatus to insert the device through a nostril or mouth of the animal into the Eustachian tube; and (c) releasing the device from the apparatus in a manner effective to allow the device to immobilize itself within the Eustachian tube, thereby rendering patent the Eustachian tube for a predetermined time period.
 24. The method of claim 23, wherein the opposing surfaces are substantially planar. 